Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for sedation in painless endoscopy
ChiCTR2000039582Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Sedation success rate. Started Nov 2020; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000039582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039582.